{
    "code": "52027106",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027106",
    "time": "2017-05-05 03:31:58",
    "許可證字號": "衛部藥輸字第027106號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/04\/05",
    "發證日期": "106\/04\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202710600",
    "中文品名": "珍喜得平凍晶注射劑",
    "英文品名": "Gemcitabine Mylan",
    "適應症": "非小細胞肺癌、胰臟癌、膀胱癌、膽道癌。GEMCITABINE與PACLITAXEL併用，可使用於曾經使用過ANTHRACYCLINE之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑類藥物(PLATINUM-BASED)治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。",
    "劑型": "243凍晶注射劑",
    "包裝": "200毫克、1公克玻璃小瓶裝 各100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "GEMCITABINEHYDROCHLORIDE"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201118216  台灣邁蘭有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F200921000  MYLAN LABORATORIES LIMITED-OTL",
        "製造廠廠址": "PLOT NO. 284B, BOMMASANDRA-JIGANI LINK ROAD, INDUSTRIAL AREA, ANEKAL TALUK, BANGALORE-560105, INDIA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(Equivalent to Gemcitabine)",
            "含量": "0.2000000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(Equivalent to Gemcitabine)",
            "含量": "1.0000000000",
            "單位": "GM"
        }
    ]
}